Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean cristian orellana[Author] (3 results)?
Management of Dyslipidemia With Evolocumab in Kidney Transplant Recipients.
Amaro JM, Villanego F, Orellana CD, Vigara LA, Alonso M, García T, Mazuecos A. Amaro JM, et al. Among authors: orellana cd. Transplantation. 2024 May 1;108(5):e74-e76. doi: 10.1097/TP.0000000000004942. Epub 2024 Apr 24. Transplantation. 2024. PMID: 38317278 No abstract available.
Lipid profile of patients treated with evolocumab in Spanish hospital nephrology units (RETOSS NEFRO).
Goicoechea M, Álvarez V, Segarra A, Polaina M, Martín-Reyes G, Robles NR, Escudero V, Orellana C, Bea Granell S, de Juan-Ribera J, Fernández Lucas M, Graña JM, Reque J, Sánchez Hernández R, Villamayor S, Górriz JL. Goicoechea M, et al. Among authors: orellana c. Nefrologia (Engl Ed). 2022 May-Jun;42(3):301-310. doi: 10.1016/j.nefroe.2022.05.005. Epub 2022 Jun 7. Nefrologia (Engl Ed). 2022. PMID: 36210619 Free article.
Lipid profile of patients treated with evolocumab in Spanish hospital nephrology units (RETOSS NEFRO).
Goicoechea M, Álvarez V, Segarra A, Polaina M, Martín-Reyes G, Robles NR, Escudero V, Orellana C, Bea Granell S, de Juan-Ribera J, Fernández Lucas M, Graña JM, Reque J, Sánchez Hernández R, Villamayor S, Górriz JL. Goicoechea M, et al. Among authors: orellana c. Nefrologia (Engl Ed). 2021 Aug 10:S0211-6995(21)00133-8. doi: 10.1016/j.nefro.2021.06.004. Online ahead of print. Nefrologia (Engl Ed). 2021. PMID: 34389184 Free article. English, Spanish.
Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease.
Naranjo J, Borrego F, Rocha JL, Salgueira M, Martín-Gomez MA, Orellana C, Morales A, Vallejo F, Hidalgo P, Rodríguez F, Garófano R, González I, Esteban R, Espinosa M. Naranjo J, et al. Among authors: orellana c. Front Med (Lausanne). 2022 Sep 29;9:987092. doi: 10.3389/fmed.2022.987092. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36250074 Free PMC article.